← Evidence map

ReviewCurrent diabetes reports2016

SGLT2 Inhibitors: Benefit/Risk Balance.

André J ScheenPubMed ↗Publisher ↗

No numbers read from the abstract.

42 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 27541294